ArticleDiabetology & metabolic syndrome2024

The relative risk of clinically relevant cholelithiasis among glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus, real-world study.

Mohammed Ali Gameil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.